UNKNOWNPHASE2/PHASE3

Remineralization Efficacy of Gum Arabic Varnish.

Remineralization Efficacy of Gum Arabic Varnish Versus Fluoride Varnish and CPP-ACP With Fluoride Based Varnish on Initial Carious Lesions. a Randomized Controlled Clinical Trial.

NCT04422860•Cairo University

View on ClinicalTrials.gov

Summary

The aim of this study is to evaluate the remineralizing capacity of Gum Arabic varnish and its implementation into clinical practice.

Eligibility

Age

17 - 40 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients with initial carious lesions.
•Proper Oral hygiene.

Exclusion Criteria

•Patients with a compromised medical history.
•Patients with active severe periodontal disease.
•Patients with hypoplastic or hypomineralized teeth.

Locations (1)

Faculty of Dentistry

Cairo, Egypt

Key Dates

Start Date

October 1, 2020

Primary Completion Date

September 1, 2021

Completion Date

November 1, 2021

Last Updated

July 13, 2020

Enrollment

90

ESTIMATED participants

Conditions

Caries,DentalRemineralizationWhite Spot Lesion

Interventions

Gum Arabic varnish

DRUG

Proflourid Varnish,VOCO

DRUG

MI Varnish,GC Japan Inc.

DRUG

Contacts

Rawda H. A.ElAziz, Post Phd

CONTACT

00201001097200 rawda.hesham@dentistry.cu.edu.eg

Ahmed H. Samaha, BSc

CONTACT

Ahmed.hesham@dentistry.cu.edu.eg

Resin Infiltration Vs Self-Assembling Peptide (P11-4) in Treating White Spot Lesions

NCT06708481

White Spot Lesion

View study

RECRUITINGNA

Comparison of the Treatment Outcomes of the Conventional Stainless Steel Crown Restorations and the Hall Technique in the Treatment of Carious Primary Molars

NCT06597669

Caries,Dental

View study

RECRUITINGNA

Evaluation of Antimicrobial, Post Operative Pain of Cinnamon Extract Versus Sodium Hypochlorite Irrigant Following Pulpectomy of Primary Teeth

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 13, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

NCT05860712

Irreversible PulpitisCaries,Dental

View study

RECRUITING